Angelalign Technology (SEHK:6699) Valuation Check After Strong Results And Special Dividend Announcement

Angelalign Technology (SEHK:6699) has put investors on alert after reporting its 2025 full year results, alongside a proposed special dividend of HK$4.99 per share and an affirmed annual dividend.

See our latest analysis for Angelalign Technology.

The stock has reacted positively around these announcements, with a 7 day share price return of 12.35% and a 90 day share price return of 24.41%. However, the 1 year total shareholder return of 32.29% contrasts with a 3 year total shareholder return of a 32.84% decline, suggesting recent momentum after a tougher multi year period.

If you are weighing Angelalign against other opportunities in healthcare and orthodontics, this could be a good moment to see what else is moving in related AI driven treatments via 120 healthcare AI stocks

With earnings and dividends now on the table and the share price already moving, the real question is whether Angelalign still trades at a discount or if the latest results and payouts are already fully reflected in the price.

Preferred P/E of 56.8x: Is it justified?

Angelalign is currently trading on a P/E of 56.8x, which looks expensive when set against both peer companies and what some models suggest might be a more typical level.

The P/E multiple compares the current share price to earnings per share, so a higher figure usually reflects stronger profit expectations or a willingness to pay up for growth. For a specialist clear aligner and dental services business, that can signal investors are pricing in meaningful future expansion and earnings resilience rather than treating the company like a mature, slow growth healthcare name.

Compared with the Hong Kong Medical Equipment industry average P/E of 17.7x, Angelalign trades at a much richer valuation. It is also described as expensive versus its broader peer group average of 39.1x, which suggests the market is assigning a premium relative to similar companies. Against an estimated fair P/E of 20.1x, the current multiple sits at a materially higher level that some models indicate the market could eventually move closer to if expectations cool.

Explore the SWS fair ratio for Angelalign Technology

Result: Preferred multiple of P/E 56.8x (OVERVALUED)

However, the premium P/E and recent share price gains could be vulnerable if earnings growth or dividend plans disappoint, or if sentiment toward healthcare names cools.

Find out about the key risks to this Angelalign Technology narrative.

Another view: DCF points in the opposite direction

While the 56.8x P/E suggests Angelalign is expensive, our DCF model tells a different story. In this view, the shares at HK$74.15 sit about 15.9% below an estimated future cash flow value of HK$88.18, which implies investors are paying less for the cash the business is expected to generate. So which signal matters more to you: the current earnings multiple, or the cash flow picture?

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Angelalign Technology for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 253 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With mixed signals from P/E and DCF in mind, this is a good time to look through the details yourself and decide how comfortable you are with the current setup. From there, you can weigh the balance of 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If Angelalign has your attention, do not stop here. Use the rest of your research time to scan other potential opportunities before the market moves on.

• Spot potential value candidates early by checking companies that appear on the 253 high quality undervalued stocks.
• Target income focused opportunities by reviewing businesses featured in the 468 dividend fortresses.
• Prioritize resilience by searching companies highlighted in the 262 resilient stocks with low risk scores.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com